Friday, July 10, 2026

Drug profile · INN

pentazocine lactate

pentazocine lactate (TALWIN) is a sigma opioid receptor modulator. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pentazocine lactate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

pentazocine lactate (TALWIN) is a sigma opioid receptor modulator. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN pentazocine lactate
Brand TALWIN
Mechanism Sigma opioid receptor modulator
Target Sigma non-opioid intracellular receptor 1
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Sigma opioid receptor modulator

Primary target: Sigma non-opioid intracellular receptor 1

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. pentazocine hydrochloride Sigma opioid receptor modulator

Frequently asked questions

What is pentazocine lactate?

pentazocine lactate (TALWIN) is a sigma opioid receptor modulator. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for pentazocine lactate?

TALWIN is a marketed brand name for pentazocine lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of pentazocine lactate?

pentazocine lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.